EFFECT OF THE AGONIST OF PPAR-y, ROSIGLITAZONE, ON LIPID PROFILE AND GLUCOSE TOLERANCE IN BRAZILIAN OBESE SUBJECTS.

Autor: Barroso, S G, Genelhu-Fagundes, V, Duarte, S FP, Rodrigues, M LG, Valença, D CT, Sanjuliani, A F, Pimentel, M MG, Francischetti, E A
Zdroj: Journal of Hypertension; 2004 Supplement 1, Vol. 22, pS101-S101, 1p
Databáze: Complementary Index